Icagen Announces Extension of Pfizer Collaboration
21 sept. 2009 08h15 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced a one year extension to a prior worldwide collaboration and licensing agreement with Pfizer...
Icagen Reports Top Line Results of Phase IIa Study of Senicapoc in Allergic Asthma
01 sept. 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 1, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today top line results of a randomized, double-blind, placebo-controlled, proof-of-mechanism Phase...
Icagen to Present At Upcoming Healthcare Conferences
31 août 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 31, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in two upcoming healthcare conferences as follows:...
Icagen Reports Second Quarter 2009 Financial Results
04 août 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 4, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the second quarter ended June 30, 2009....
Icagen Announces Lifting of Partial Clinical Hold of ICA-105665
03 août 2009 06h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today that the FDA has lifted the partial clinical hold related to the development of ICA-105665, the...
Icagen to Report Second Quarter 2009 Results On August 4, 2009
23 juil. 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., July 23, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release second quarter 2009 financial results on Tuesday, August 4, 2009 before the...
Icagen Completes Enrollment in Phase II Exercise Induced Asthma Trial
12 juin 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., June 12, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported the completion of enrollment in the Company's Phase II proof-of-concept study of senicapoc in...
Icagen Provides Strategic Update
04 juin 2009 16h36 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., June 4, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that the Company has retained J.P. Morgan to provide advice and assistance on a range of...
Icagen Reports First Quarter 2009 Financial Results and Operational Highlights
05 mai 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., May 5, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the first quarter ended March 31, 2009. For...
Icagen to Report First Quarter 2009 Results On May 5, 2009
24 avr. 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 24, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release first quarter 2009 financial results on Tuesday, May 5, 2009 before the...